Goldman Sachs’s Inogen INGN Stock Holding History
Bought
Maintained
Sold
Other funds holding INGN
AC
DCM
Goldman Sachs's INGN Position: Q2 2026 in Review
Goldman Sachs reduced its Inogen (INGN) stake by 25% in Q2 2026, selling an estimated $956K and leaving 435,585 shares worth $2.81M. The position accounts for ﹤0.01% of the portfolio, ranked #4399.
Goldman Sachs first reported a position in INGN in Q2 2014 and has held it in 45 quarters since. The position peaked at $50.9M in Q3 2018. 129 funds tracked by Wall St. Rank hold INGN as of Q2 2026.
- Goldman Sachs held 435,585 shares of Inogen worth $2.81M as of Q2 2026.
- Goldman Sachs sold 144,515 Inogen shares in Q2 2026, an estimated $956K.
- Inogen made up ﹤0.01% of Goldman Sachs's portfolio in Q2 2026, its #4399 holding.
- Goldman Sachs first reported a position in Inogen in Q2 2014 and has held it in 45 quarters since.
- Goldman Sachs's Inogen position peaked at $50.9M in Q3 2018.
- 129 funds tracked by Wall St. Rank held Inogen as of Q2 2026.
Based on Goldman Sachs's 13F filing for Q2 2026, filed 14 Aug 2026.